Total Payments
$635.53
2024 Payments
$72.15
Companies
17
Transactions
38
Medicare Patients
3,107
Medicare Billing
$341,162
Payment Breakdown by Category
Food & Beverage$635.53 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $635.53 | 38 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $121.34 | 9 | $0 (2024) |
| Tepha Inc | $86.66 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $82.70 | 5 | $0 (2023) |
| Amgen Inc. | $49.08 | 3 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $44.25 | 4 | $0 (2017) |
| ABBVIE INC. | $34.17 | 2 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $27.69 | 2 | $0 (2017) |
| Radius Health, Inc. | $25.03 | 2 | $0 (2019) |
| Genentech USA, Inc. | $24.35 | 2 | $0 (2020) |
| Synergy Pharmaceuticals Inc | $24.29 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $72.15 | 4 | ABBVIE INC. ($20.08) |
| 2023 | $82.61 | 5 | AstraZeneca Pharmaceuticals LP ($35.90) |
| 2022 | $49.60 | 3 | Amgen Inc. ($35.51) |
| 2021 | $12.79 | 1 | GlaxoSmithKline, LLC. ($12.79) |
| 2020 | $55.28 | 4 | GlaxoSmithKline, LLC. ($29.78) |
| 2019 | $57.31 | 4 | Radius Health, Inc. ($25.03) |
| 2018 | $159.05 | 6 | Tepha Inc ($86.66) |
| 2017 | $146.74 | 11 | Sunovion Pharmaceuticals Inc. ($44.25) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Cardio-renal | ||||||
| 06/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: NEUROSCIENCE | ||||||
| 04/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/10/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Biological | ||||||
| 05/15/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Diabetes | ||||||
| 02/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/06/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Bone Health | ||||||
| 11/21/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Bone Health | ||||||
| 11/07/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Inflammation | ||||||
| 01/25/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: RESPIRATORY | ||||||
| 12/14/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: Virology & Specialty Care | ||||||
| 10/26/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Respiratory | ||||||
| 12/19/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Virology & Specialty Care | ||||||
| 12/09/2019 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: Endocrinology | ||||||
| 03/11/2019 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Endocrinology | ||||||
| 02/25/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Respiratory | ||||||
| 12/03/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2018 | Tepha Inc | GalaFLEX (Device) | Food and Beverage | In-kind items and services | $86.66 | General |
| Category: Absorbable Biomaterial | ||||||
| 08/13/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: RESPIRATORY | ||||||
| 06/19/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 8 | 473 | 609 | $116,141 | $38,314 |
| 2021 | 17 | 1,225 | 2,227 | $379,967 | $159,291 |
| 2020 | 19 | 1,409 | 2,490 | $392,501 | $143,557 |
Total Patients
3,107
Total Services
5,326
Medicare Billing
$341,162
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 324 | 1,141 | $230,482 | $78,078 | 33.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 239 | 239 | $49,234 | $26,278 | 53.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 81 | 117 | $10,179 | $6,020 | 59.1% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 34 | 38 | $11,552 | $5,394 | 46.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 87 | 107 | $14,659 | $5,320 | 36.3% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 79 | 79 | $8,295 | $4,758 | 57.4% |
| 17000 | Destruction of skin growth | Office | 2020 | 48 | 69 | $8,487 | $2,660 | 31.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 163 | 163 | $4,401 | $2,556 | 58.1% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 19 | 19 | $3,116 | $2,247 | 72.1% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 17 | 17 | $28,713 | $2,140 | 7.5% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 19 | 25 | $4,350 | $1,865 | 42.9% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 111 | 176 | $8,448 | $1,649 | 19.5% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 80 | 80 | $2,880 | $1,527 | 53.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 11 | 14 | $1,820 | $938.10 | 51.5% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 14 | 15 | $1,500 | $573.12 | 38.2% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 22 | 129 | $1,677 | $550.76 | 32.8% |
| 69210 | Removal of impact ear wax, one ear | Office | 2020 | 14 | 15 | $1,395 | $429.01 | 30.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 25 | 25 | $675.00 | $392.58 | 58.2% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 22 | 22 | $638.00 | $180.16 | 28.2% |
About Dr. John Osborn, MD
Dr. John Osborn, MD is a Emergency Medicine healthcare provider based in Miami, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629044334.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Osborn, MD has received a total of $635.53 in payments from pharmaceutical and medical device companies, with $72.15 received in 2024. These payments were reported across 38 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($635.53).
As a Medicare-enrolled provider, Osborn has provided services to 3,107 Medicare beneficiaries, totaling 5,326 services with total Medicare billing of $341,162. Data is available for 3 years (2020–2022), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Family Medicine
- Location Miami, OK
- Active Since 02/23/2006
- Last Updated 04/05/2017
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1629044334
Products in Payments
- TRELEGY ELLIPTA (Drug) $106.13
- GalaFLEX (Device) $86.66
- FARXIGA (Drug) $35.90
- SYMBICORT (Drug) $32.74
- EVENITY (Biological) $31.23
- Tymlos (Biological) $25.03
- Xofluza (Drug) $24.35
- Trulance (Drug) $24.29
- UTIBRON (Drug) $23.24
- BROVANA (Drug) $21.01
- UBRELVY (Drug) $20.08
- TRULICITY (Drug) $19.09
- VOQUEZNA (Drug) $18.69
- Kerendia (Drug) $17.92
- Belviq (Drug) $17.86
- Otezla (Drug) $17.85
- NAMZARIC (Drug) $15.24
- BREO (Drug) $15.21
- APIDRA (Drug) $14.59
- QULIPTA (Drug) $14.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Miami
Patricia Panakos, M.d, M.D
Emergency Medicine — Payments: $86,387
Emergency Medicine $86,387
Girish Kapur, M.d. M.p.h, M.D. M.P.H
Emergency Medicine — Payments: $45,000
Emergency Medicine $45,000
Dr. Carlos Bello, Md, MD
Emergency Medicine — Payments: $17,680
Emergency Medicine $17,680
Dr. Ivette Motola, Md, Mph, MD, MPH
Emergency Medicine — Payments: $8,891
Emergency Medicine $8,891
Dr. David Mishkin, M.d, M.D
Emergency Medicine — Payments: $6,701
Emergency Medicine $6,701
Mauricio Trujillo, M.d, M.D
Emergency Medicine — Payments: $3,477
Emergency Medicine $3,477